[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Amgen, Inc. Graphic](https://lunarcrush.com/gi/w:26/t:$amgn.png) Amgen, Inc. (AMGN)

FDA approves Tezspire for chronic rhinosinusitis with nasal polyps, a major win for Amgen and AstraZeneca. Amgen's stock is trending positively with increased social dominance and market cap gains.

### About Amgen, Inc.
Amgen, Inc. (AMGN) is a biotechnology company focused on developing and delivering innovative human therapeutics.  
Amgen, Inc. uses the ticker $AMGN for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$amgn/insights)
- Amgen, Inc. (AMGN) social dominance is up XXXXX% from the previous week.

### Price: $XXXXXX [#](/topic/$amgn/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/close.tsv)  
The price is currently at $277.50, with a XXXX% increase in the last XX hours, and positive sentiment and news about Amgen's advancements, along with the market cap, suggest a bullish trend.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXX%   |

**1-Year High**: $XXXXXX on 2025-03-10  
**1-Year Low**: $XXXXXX on 2025-01-06  
  
  
### AltRank: XXXXX [#](/topic/$amgn/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/alt_rank.tsv)  
Amgen, Inc. (AMGN) is currently AltRank #1,164 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +391  
**1 Month**: XXXXX +407  
**6 Months**: XXXXX +821  
**1 Year**: XXXXX +646  
**1-Year High**: XXXXX on 2024-11-02  
**1-Year Low**: XX on 2024-12-29  
  
  
### Galaxy Score: XXXXX [#](/topic/$amgn/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -X  
**1 Month**: XX -X  
**6 Months**: XX -XX  
**1 Year**: XX -X  
**1-Year High**: XX on 2025-05-27  
**1-Year Low**: X on 2024-11-11  
  
  
### Engagements: XXXXXX [#](/topic/$amgn/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXXXX -XX%  
**6 Months**: XXXXXXXXXX +5.40%  
**1 Year**: XXXXXXXXXX -XX%  
**1-Year High**: XXXXXXXXX on 2025-02-04  
**1-Year Low**: XXXXX on 2025-10-19  

| Social Network | X     | TikTok | News | YouTube | Reddit |
| -------------- | -     | ------ | ---- | ------- | ------ |
| Engagements    | XXXXX | XXXXX  | XXX  | XXXXX   | XXX    |
  

  
  
### Mentions: XXX [#](/topic/$amgn/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +12%  
**1 Year**: XXXXXX +1.50%  
**1-Year High**: XXXXX on 2024-11-28  
**1-Year Low**: XXX on 2025-01-27  

| Social Network | X   | TikTok | News | YouTube | Reddit |
| -------------- | -   | ------ | ---- | ------- | ------ |
| Mentions       | XXX | XX     | X    | XX      | X      |
  

  
  
### Creators: XXX [#](/topic/$amgn/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Amgen, Inc. (AMGN) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXX +56%  
**1 Year**: XXXXXX +103%  
**1-Year High**: XXX on 2025-09-04  
**1-Year Low**: XX on 2025-01-26  

The most influential creators that mention Amgen, Inc. in the last XX hours

| Creator                                                      | Rank | Followers   | Posts | Engagements |
| -------                                                      | ---- | ---------   | ----- | ----------- |
| [@dpworldtour](/creator/youtube/dpworldtour)                 | X    | XXXXXXX     | X     | XXXXX       |
| [@amgen](/creator/youtube/amgen)                             | X    | XXXXXX      | XX    | XXX         |
| [@A1PHAEDGE](/creator/twitter/A1PHAEDGE)                     | X    | XXX         | XX    | XXX         |
| [@nucleusmedicalmedia](/creator/youtube/nucleusmedicalmedia) | X    | XXXXXXXXX   | X     | XXX         |
| [@everybodylies36](/creator/twitter/everybodylies36)         | X    | XXXXX       | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)                   | X    | XXXXXX      | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)             | X    | XXXXX       | X     | XXX         |
| [@amgenbiotech](/creator/tiktok/amgenbiotech)                | X    | XXXXX       | XX    | XXX         |
| [@PRNewswire](/creator/twitter/PRNewswire)                   | X    | XXXXXXXXXXX | X     | XXX         |
| [@arpita37898816](/creator/twitter/arpita37898816)           | XX   | XXX         | X     | XXX         |

[View More](/list/creators/$amgn/100)
  
  
### Sentiment: XX% [#](/topic/$amgn/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% -X%  
**6 Months**: XX% -X%  
**1 Year**: XX% -X%  
**1-Year High**: XX% on 2025-09-07  
**1-Year Low**: XX% on 2024-11-26  

**Most Supportive Themes**
- **Positive Sentiment and News Mentions:** (40%) Posts highlighting Amgen's advancements and positive news coverage.
- **Product and Partnership Announcements:** (30%) Announcements regarding new products, partnerships, and clinical trial results.
- **Industry Recognition and Awards:** (15%) Mentions of Amgen being recognized as a top employer and receiving industry awards.
  
**Most Critical Themes**
- **Market and Economic Concerns:** (10%)  Posts expressing concerns about market dominance and potential impacts of tariffs and economic factors.
- **Competition and Market Dynamics:** (5%)  Discussions about competitors and the competitive landscape in the pharmaceutical industry.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| TikTok  | XXX      | X%  | XXX     | X%  | XX       | X% |
| News    | XXX      | X%  | XX      | X%  | X        | X% |
| YouTube | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$amgn/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.018%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-11-27  
**1-Year Low**: XXXXX% on 2025-07-29  
  
  
### Market Dominance: XXXXX% [#](/topic/$amgn/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-12  
**1-Year Low**: XXXX% on 2025-09-25  
  
  
### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/$amgn/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$amgn/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXXX +$2.60%  
**1 Month**: $XXXXXXXXXXXXXXX +$8.30%  
**6 Months**: $XXXXXXXXXXXXXXX +$9.30%  
**1 Year**: $XXXXXXXXXXXXXXX -$7%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-03-10  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2025-01-06  

**Top assets mentioned**
In the posts about Amgen, Inc. in the last XX hours

[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[AbbVie Inc (ABBV)](/topic/$abbv)
[QUALCOMM, Inc. (QCOM)](/topic/$qcom)
[Novartis AG (NVS)](/topic/novartis)
[Sanofi (SNY)](/topic/sanofi)
[Advanced Micro Devices (AMD)](/topic/advanced-micro-devices)

**Top topics mentioned**
In the posts about Amgen, Inc. in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [stocks industrials](/topic/stocks-industrials), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [stocks communication services](/topic/stocks-communication-services), [$mrk](/topic/$mrk), [eli lilly](/topic/eli-lilly), [$abbv](/topic/$abbv), [stocks financial services](/topic/stocks-financial-services), [stocks](/topic/stocks), [$qcom](/topic/$qcom), [novartis](/topic/novartis), [stocks consumer defensive](/topic/stocks-consumer-defensive), [sanofi](/topic/sanofi), [coins solana ecosystem](/topic/coins-solana-ecosystem), [advanced micro devices](/topic/advanced-micro-devices), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins base ecosystem](/topic/coins-base-ecosystem), [$tmo](/topic/$tmo), [$tmus](/topic/$tmus), [$husa](/topic/$husa), [$novnsw](/topic/$novnsw), [$aapl](/topic/$aapl), [rory](/topic/rory), [tesla](/topic/tesla), [manat](/topic/manat), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$bmy](/topic/$bmy), [$enb](/topic/$enb), [johnson johnson](/topic/johnson-johnson), [investment](/topic/investment), [$nvo](/topic/$nvo), [$hubc](/topic/$hubc), [$icon](/topic/$icon), [exxon mobil](/topic/exxon-mobil), [gilead sciences](/topic/gilead-sciences), [$gdrx](/topic/$gdrx), [has been](/topic/has-been), [stocks defense](/topic/stocks-defense), [$xbi](/topic/$xbi), [$lly](/topic/$lly), [$ecda](/topic/$ecda), [stocks basic materials](/topic/stocks-basic-materials), [$vktx](/topic/$vktx), [$ul](/topic/$ul), [$cmcsa](/topic/$cmcsa), [$nams](/topic/$nams), [tariffs](/topic/tariffs), [nasdaq](/topic/nasdaq), [approved](/topic/approved), [$unh](/topic/$unh), [$rbne](/topic/$rbne), [$mfst](/topic/$mfst), [$regn](/topic/$regn), [chronic](/topic/chronic), [ireland](/topic/ireland), [west pharmaceutical services inc](/topic/west-pharmaceutical-services-inc), [$team](/topic/$team), [stocks energy](/topic/stocks-energy), [weight loss](/topic/weight-loss), [puerto rico](/topic/puerto-rico), [money](/topic/money), [$curr](/topic/$curr), [$ibo](/topic/$ibo), [discord](/topic/discord), [coins exchange tokens](/topic/coins-exchange-tokens), [$idya](/topic/$idya), [$zlab](/topic/$zlab), [donald trump](/topic/donald-trump), [microsoft](/topic/microsoft), [coins defi](/topic/coins-defi), [investments](/topic/investments), [$smci](/topic/$smci), [$nflx](/topic/$nflx), [$pcar](/topic/$pcar), [$dtruy](/topic/$dtruy), [$bbio](/topic/$bbio), [$indo](/topic/$indo), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$wmt](/topic/$wmt), [$googl](/topic/$googl), [$xene](/topic/$xene), [beam beam therapeutics inc](/topic/beam-beam-therapeutics-inc), [$beam](/topic/$beam), [dp](/topic/dp), [$spy](/topic/$spy), [acquisition](/topic/acquisition), [$novcde](/topic/$novcde), [$rhhby](/topic/$rhhby), [$bull](/topic/$bull), [$bmrn](/topic/$bmrn), [discount](/topic/discount), [$mlr](/topic/$mlr), [adobe inc](/topic/adobe-inc), [procter gamble](/topic/procter-gamble), [walt disney](/topic/walt-disney), [bitmine](/topic/bitmine), [$wst](/topic/$wst)

### Top News [#](/topic/$amgn/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS"  
[News Link](https://www.prnewswire.com/news-releases/fda-approves-tezspire-for-chronic-rhinosinusitis-with-nasal-polyps-302587969.html) [@PRNewswire](/creator/x/PRNewswire) 2025-10-17T20:02Z 208.1M followers, 1135 engagements


"Marjorie Taylor Greene and Cathie Wood Share XX Stocks - Advanced Micro Devices (NASDAQ:AMD) Amgen (NASDAQ:AMGN) - Benzinga"  
[News Link](https://www.benzinga.com/news/politics/25/10/48265417/marjorie-taylor-greene-cathie-wood-snap-up-the-same-13-stocks-heres-the-unlikely-portfolio-crossover) [@Benzinga](/creator/x/Benzinga) 2025-10-16T21:35Z 315.4K followers, XXX engagements



### Top Social Posts [#](/topic/$amgn/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"AMGN Q2 snapshot: Repatha +31% to $696M; UPLIZNA +91% to $176M. R&D +20% as late-stage pipeline spending ramps. Cost of revenue down X% despite oncology/volume pressures; $213M favorable OI&E aided other costs. $AMGN #earnings #biotech #investing"  
[X Link](https://x.com/earnings_games/status/1979793831030886743) [@earnings_games](/creator/x/earnings_games) 2025-10-19T06:16Z XXX followers, XX engagements


"US FDA expands use of Amgen AstraZeneca's drug for chronic inflammatory sinus disease The U.S. FDA has approved Amgen and AstraZeneca's drug Tezspire for use as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps in "  
[X Link](https://x.com/jobrx/status/1979774554588237923) [@jobrx](/creator/x/jobrx) 2025-10-19T05:00Z 7128 followers, XX engagements


"best discord room $LLY $TMO $AMGN $AZN $NKECHL $COST $MCD $ACN $BMY $DHR $NEE $SNY $CHTR $MDT $TMUS"  
[X Link](https://x.com/arpita37898816/status/1979641492982599705) [@arpita37898816](/creator/x/arpita37898816) 2025-10-18T20:11Z XXX followers, XXX engagements


"Enter: $AMGN NOV XX 2025 $XXX CALLS Buy in Price: $XXXX - $XXXXX Take Profit: $XXXXX Stop Bleeding: $XXXX ROI Potential: XX% Exit Within: X Weeks"  
[X Link](https://x.com/OptionsAlertsAi/status/1979627666564341820) [@OptionsAlertsAi](/creator/x/OptionsAlertsAi) 2025-10-18T19:16Z XXX followers, XX engagements